According to the Zhitong Finance App, Kehua Biotech (002022.SZ) announced that the company has received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. The product name is calcitonin determination kit (chemiluminescence) for medical institutions to quantitatively measure calcitonin (CT) concentration in human serum or plasma samples in vitro for auxiliary diagnosis.
Kehua Biotech (002022.SZ): Calcitonin determination kit (chemiluminescence method) obtained medical device registration certificate
Zhitong Finance · 06/21/2023 20:04
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.